ReviewTargeted oncology2025

IDH1/2 Mutations in Cancer: Unifying Insights and Unlocking Therapeutic Potential for Chondrosarcoma.

Shriya Deshmukh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.